 PALO ALTO, Calif., Sept. 1, 2021 PRNewswire -- Eiger BioPharmaceuticals, Inc. Nasdaq: EIGR, a commercial-stage biopharmaceutical company focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced that David Cory, President and CEO, will participate in two investor conference events in September: Citis 16th Annual BioPharma Virtual Conference Finding a Needle in a Haystack Drug Development Strategies for Rare Disease panel discussion Thursday, September 9 at 4:10 PM ET Bairds 2021 Global Healthcare Conference Corporate update Wednesday, September 15 at 2:00 PM ET Eiger will also host one-on-meetings with investors at both conferences. 